Each manufacturer of a device that is intended for surgical implant into the body or to support or sustain life and whose failure to perform when properly used in accordance with instructions for use provided in the labeling can be reasonably expected to result in a significant injury to the user shall establish and maintain procedures for identifying with a control number each unit, lot, or batch of finished devices and where appropriate components. The procedures shall facilitate corrective action. Such identification shall be documented in the DHR. Subpart G—Production and Process Controls
21 CFR Part 820 · Quality Management System Regulation
§ 820.65 Traceability
Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.
What FDA inspectors cite under § 820.65
Form FDA 483 observations citing this section, fiscal years 2011–2019 (Devices).
- Traceability Lack of or inadequate {see also 820.120(e)} 6
Warning letters citing § 820.65
1 FDA warning letters since 2017 cite this section :
- LEVO AG 18 Jul 2025